Cite
HARVARD Citation
Feng, J. et al. (2022). Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Protein & cell. 13 (11), pp. 825-841. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Feng, J. et al. (2022). Genome-wide CRISPR screen identifies synthetic lethality between DOCK1 inhibition and metformin in liver cancer. Protein & cell. 13 (11), pp. 825-841. [Online].